Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
91,148,433
-
Share change
-
-487,071
-
Total reported value
-
$10,855,978,310
-
Put/Call ratio
-
87%
-
Price per share
-
$119.10
-
Number of holders
-
282
-
Value change
-
-$71,676,389
-
Number of buys
-
154
-
Number of sells
-
112
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q1 2018
As of 31 Mar 2018 ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) had 282 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 91,148,433 shares of stock of the company.
Largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., DODGE & COX, BAILLIE GIFFORD & CO, STATE STREET CORP, UBS ASSET MANAGEMENT AMERICAS INC, and PERCEPTIVE ADVISORS LLC.
This table shows 283 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.